Be in the know. 20 key reads for Tuesday…

  1. US banks in line for windfall after Covid-19 vaccine progress (Financial Times)
  2. Berkshire Appears to Have Sold $4 Billion of Apple Stock in Third Quarter (Barron’s)
  3. Pfizer’s Vaccine News Sends Stock Market’s Biggest 2020 Losers Soaring (Barron’s)
  4. Eli Lilly Covid Antibody Drug Gets Emergency FDA Clearance (Bloomberg)
  5. EU hits Amazon with antitrust charges for distorting competition in online retail markets (CNBC)
  6. Homebuilder DR Horton posts 81% sales spike (Fox Business)
  7. Vaccine Has Wall Street Ready to Suit Back Up (Wall Street Journal)
  8. Bank Stocks Break Out on Upbeat Covid-19 Vaccine Data (Barron’s)
  9. CureVac’s stock is up 8% as it shares additional Phase 1 data about its COVID-19 vaccine candidate (MarketWatch)
  10. Ulta Beauty shop-in-shops coming to 100 Target stores in 2021 (MarketWatch)
  11. While the Pandemic Wrecked Some Businesses, Others Did Fine. Even Great. (New York Times)
  12. Pfizer, Eli Lilly Breakthroughs Provide Hope for Ending Pandemic (Bloomberg)
  13. Stanley Druckenmiller says he wouldn’t want to be short market, sees stock rotation continuing (CNBC)
  14. 12 Stocks Are Still Cheap After Huge Vaccine And Election Rally (Investor’s Business Daily)
  15. Boeing (BA) Surges on Vaccine News and Likely 737 MAX Ungrounding (streetinsider)
  16. Pfizer COVID-19 vaccine could be given by the end of the year, says Fauci (MarketWatch)
  17. Why Vaccine News Is Such Good News for GE Stock (Barron’s)
  18. Want to travel at 600 mph in a tube? It could happen (USA Today)
  19. Here are the 2 big signals that stocks need to keep moving higher, says Credit Suisse’s top equity strategist (MarketWatch)
  20. Small caps break to record high for first time since 2018 (CNBC)